-
Published 12/1/2025
Hadland SE, Kimmel SD, Yan S, Bettano AL, Lo-Ciganic WH, Bagley SM, Calihan JB, Hsu HE, Larochelle MR. Buprenorphine Treatment Duration and Adherence Among Youth and Subsequent Health Outcomes. Pediatrics. 2025 Dec 01; 156(6). PMID: 41248890.
-
Published 11/26/2025
Westerman CA, Nielsen K, Flynn D, Yule AM, Calihan JB, Hadland SE, Bagley SM. A Scoping Review of Clinical Trials Evaluating Medications for Adolescents With Substance Use Disorders. J Addict Med. 2025 Nov 26. PMID: 41481865.
-
Published 10/30/2025
Chatterjee A, Chase RP, Chahine RA, Davis J, Dsouza N, Ellison S, Bagley SM, Fisher T, Glasgow L, Harris MTH, Huang TT, Holloway J, Lounsbury DW, Oga E, Asman K, Roberts SM, Sabounchi N, Surratt HL, Lines LM, Stadler HW, Taylor JL, Davis A. Local level of social inequity moderates implementation of evidence-based practices tailored to minoritized populations to reduce opioid overdose deaths. J Subst Use Addict Treat. 2026 Jan; 180:209828. PMID: 41175975.
-
Published 9/10/2025
Walley AY, Wang J, To C, Duska M, Murray S, Wiggins M, Rolles A, Yan S, Kosakowski S, Bagley SM, Xuan Z, Hyde J, Formica SW. Post-overdose outreach programs in Massachusetts before and after the onset of the COVID-19 pandemic. J Subst Use Addict Treat. 2025 Dec; 179:209799. PMID: 40939693.
-
Published 9/1/2025
Cano M, Hernandez N, Mendoza NS, Bagley SM. Fewer Than 1 In 3 Adolescents With Past-Year Opioid Use Disorder Received Substance Use Treatment, 2022-23. Health Aff (Millwood). 2025 Sep; 44(9):1060-1069. PMID: 40893078.